vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and PARK NATIONAL CORP (PRK). Click either name above to swap in a different company.

COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $168.3M, roughly 1.2× PARK NATIONAL CORP). PARK NATIONAL CORP runs the higher net margin — 25.3% vs 8.3%, a 17.1% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 2.2%). PARK NATIONAL CORP produced more free cash flow last quarter ($191.9M vs $122.4M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 4.9%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

National Retail Systems, Inc. (NRS) includes Keystone Freight Corp. & National Retail Transportation, Inc. (NRT). NRS is an asset based 3PL founded in 1952. It is headquartered in Lyndhurst, New Jersey, United States.

COLL vs PRK — Head-to-Head

Bigger by revenue
COLL
COLL
1.2× larger
COLL
$205.4M
$168.3M
PRK
Growing faster (revenue YoY)
COLL
COLL
+10.7% gap
COLL
12.9%
2.2%
PRK
Higher net margin
PRK
PRK
17.1% more per $
PRK
25.3%
8.3%
COLL
More free cash flow
PRK
PRK
$69.6M more FCF
PRK
$191.9M
$122.4M
COLL
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
4.9%
PRK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COLL
COLL
PRK
PRK
Revenue
$205.4M
$168.3M
Net Profit
$17.0M
$42.6M
Gross Margin
62.5%
Operating Margin
29.6%
Net Margin
8.3%
25.3%
Revenue YoY
12.9%
2.2%
Net Profit YoY
35.3%
10.4%
EPS (diluted)
$0.48
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
PRK
PRK
Q4 25
$205.4M
$168.3M
Q3 25
$209.4M
$169.5M
Q2 25
$188.0M
$168.7M
Q1 25
$177.8M
$157.9M
Q4 24
$181.9M
$164.7M
Q3 24
$159.3M
$170.3M
Q2 24
$145.3M
$157.7M
Q1 24
$144.9M
$152.8M
Net Profit
COLL
COLL
PRK
PRK
Q4 25
$17.0M
$42.6M
Q3 25
$31.5M
$47.2M
Q2 25
$12.0M
$48.1M
Q1 25
$2.4M
$42.2M
Q4 24
$12.5M
$38.6M
Q3 24
$9.3M
$38.2M
Q2 24
$19.6M
$39.4M
Q1 24
$27.7M
$35.2M
Gross Margin
COLL
COLL
PRK
PRK
Q4 25
62.5%
Q3 25
61.7%
Q2 25
57.7%
Q1 25
54.8%
Q4 24
54.0%
Q3 24
60.8%
Q2 24
62.5%
Q1 24
63.1%
Operating Margin
COLL
COLL
PRK
PRK
Q4 25
29.6%
Q3 25
29.7%
34.3%
Q2 25
18.7%
35.2%
Q1 25
12.2%
32.4%
Q4 24
20.9%
Q3 24
21.9%
27.4%
Q2 24
32.7%
30.6%
Q1 24
34.1%
27.8%
Net Margin
COLL
COLL
PRK
PRK
Q4 25
8.3%
25.3%
Q3 25
15.0%
27.8%
Q2 25
6.4%
28.5%
Q1 25
1.4%
26.7%
Q4 24
6.9%
23.5%
Q3 24
5.9%
22.4%
Q2 24
13.5%
25.0%
Q1 24
19.1%
23.0%
EPS (diluted)
COLL
COLL
PRK
PRK
Q4 25
$0.48
$2.62
Q3 25
$0.84
$2.92
Q2 25
$0.34
$2.97
Q1 25
$0.07
$2.60
Q4 24
$0.36
$2.38
Q3 24
$0.27
$2.35
Q2 24
$0.52
$2.42
Q1 24
$0.71
$2.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
PRK
PRK
Cash + ST InvestmentsLiquidity on hand
$386.7M
$233.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$301.7M
$1.4B
Total Assets
$1.7B
$9.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
PRK
PRK
Q4 25
$386.7M
$233.5M
Q3 25
$285.9M
$218.9M
Q2 25
$222.2M
$193.1M
Q1 25
$197.8M
$237.6M
Q4 24
$162.8M
$160.6M
Q3 24
$120.0M
$201.7M
Q2 24
$271.6M
$261.5M
Q1 24
$318.0M
$306.1M
Stockholders' Equity
COLL
COLL
PRK
PRK
Q4 25
$301.7M
$1.4B
Q3 25
$274.8M
$1.3B
Q2 25
$232.2M
$1.3B
Q1 25
$234.4M
$1.3B
Q4 24
$228.8M
$1.2B
Q3 24
$234.3M
$1.2B
Q2 24
$216.6M
$1.2B
Q1 24
$222.2M
$1.2B
Total Assets
COLL
COLL
PRK
PRK
Q4 25
$1.7B
$9.8B
Q3 25
$1.6B
$9.9B
Q2 25
$1.6B
$9.9B
Q1 25
$1.6B
$9.9B
Q4 24
$1.7B
$9.8B
Q3 24
$1.6B
$9.9B
Q2 24
$1.1B
$9.9B
Q1 24
$1.1B
$9.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
PRK
PRK
Operating Cash FlowLast quarter
$123.0M
$198.3M
Free Cash FlowOCF − Capex
$122.4M
$191.9M
FCF MarginFCF / Revenue
59.6%
114.1%
Capex IntensityCapex / Revenue
0.3%
3.8%
Cash ConversionOCF / Net Profit
7.25×
4.65×
TTM Free Cash FlowTrailing 4 quarters
$327.6M
$328.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
PRK
PRK
Q4 25
$123.0M
$198.3M
Q3 25
$78.4M
$52.6M
Q2 25
$72.4M
$49.7M
Q1 25
$55.4M
$37.9M
Q4 24
$84.6M
$178.8M
Q3 24
$-9.0M
$43.8M
Q2 24
$67.4M
$50.9M
Q1 24
$61.9M
$35.0M
Free Cash Flow
COLL
COLL
PRK
PRK
Q4 25
$122.4M
$191.9M
Q3 25
$78.3M
$51.1M
Q2 25
$72.4M
$48.4M
Q1 25
$54.6M
$36.8M
Q4 24
$84.1M
$169.7M
Q3 24
$-9.2M
$41.7M
Q2 24
$67.1M
$49.0M
Q1 24
$61.4M
$31.9M
FCF Margin
COLL
COLL
PRK
PRK
Q4 25
59.6%
114.1%
Q3 25
37.4%
30.1%
Q2 25
38.5%
28.7%
Q1 25
30.7%
23.3%
Q4 24
46.2%
103.0%
Q3 24
-5.8%
24.5%
Q2 24
46.2%
31.1%
Q1 24
42.3%
20.8%
Capex Intensity
COLL
COLL
PRK
PRK
Q4 25
0.3%
3.8%
Q3 25
0.1%
0.9%
Q2 25
0.0%
0.8%
Q1 25
0.4%
0.7%
Q4 24
0.3%
5.6%
Q3 24
0.2%
1.2%
Q2 24
0.2%
1.2%
Q1 24
0.4%
2.1%
Cash Conversion
COLL
COLL
PRK
PRK
Q4 25
7.25×
4.65×
Q3 25
2.49×
1.11×
Q2 25
6.05×
1.03×
Q1 25
22.92×
0.90×
Q4 24
6.75×
4.63×
Q3 24
-0.96×
1.14×
Q2 24
3.44×
1.29×
Q1 24
2.23×
0.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons